Imidazole macrocycles for the treatment of autoimmune disease

The present invention relates to compounds of formula (Ia), wherein R2, M1, M2, M3, Q1 and Q2 are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.

Saved in:
Bibliographic Details
Main Authors GUBA, WOLFGANG, LIN, ZHAO-HU, WU, YAO, ZHU, WEI, ZHANG, WEI-XING, ZHANG, ZHI-WEI, LIU, YA-FEI, ZHANG, ZHEN-HONG, JIANG, MIN, LIU, HAI-XIA, HAN, XINGUN, ZHU, JIAN-SHENG, KOU, BU-YU, CHEN, JIAN-GUO, CHEN, SHUAI, SHEN, HONG
Format Patent
LanguageChinese
English
Published 01.11.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of formula (Ia), wherein R2, M1, M2, M3, Q1 and Q2 are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
Bibliography:Application Number: TW202312103466